Kazuo Ono

Wakayama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Acute development of EBV+ T-cell lymphoproliferative disorder after treatment with rituximab for follicular lymphoma.

Acute development of EBV+ T-cell lymphoproliferative disorder after treatment with rituximab for follicular lymphoma.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: July 07, 2026

Hematologic responses with favorable safety in three elderly patients with polycythemia vera treated with ropeginterferon alfa-2b

Hematologic responses with favorable safety in three elderly patients with polycythemia vera treated with ropeginterferon alfa-2b

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: March 29, 2026

Small Hepatoid Variant of Solid Pseudopapillary Neoplasm of the Pancreas: A Unique Case With Long-term Follow-up.

Small Hepatoid Variant of Solid Pseudopapillary Neoplasm of the Pancreas: A Unique Case With Long-term Follow-up.

Journal: DEN open

Published: January 09, 2026

Reduced dose and shorter duration venetoclax regimens are effective for newly diagnosed acute myeloid leukemia patients not considered fit for intensive treatment.

Reduced dose and shorter duration venetoclax regimens are effective for newly diagnosed acute myeloid leukemia patients not considered fit for intensive treatment.

Journal: Leukemia & lymphoma

Published: December 25, 2025

Large, White Globe Appearance-Like Endoscopic Findings: Stomach Lymphatic Invasion Distant From Advanced Gastric Cancer.

Large, White Globe Appearance-Like Endoscopic Findings: Stomach Lymphatic Invasion Distant From Advanced Gastric Cancer.

Journal: Journal of gastroenterology and hepatology

Published: November 10, 2025

Effective Treatment with Ruxolitinib and Ropeginterferon Alfa-2b for Refractory TAFRO-like Syndrome.

Effective Treatment with Ruxolitinib and Ropeginterferon Alfa-2b for Refractory TAFRO-like Syndrome.

Journal: Internal medicine (Tokyo, Japan)

Published: October 29, 2025

Intramucosal Alpha-Fetoprotein-producing Early Gastric Cancer Without Vascular Invasion or Metastasis Diagnosed After Endoscopic Submucosal Dissection: A Case Report and Literature Review.

Intramucosal Alpha-Fetoprotein-producing Early Gastric Cancer Without Vascular Invasion or Metastasis Diagnosed After Endoscopic Submucosal Dissection: A Case Report and Literature Review.

Journal: DEN open

Published: September 03, 2025

A case of small undifferentiated pancreatic carcinoma detected during follow-up for focal pancreatic parenchymal atrophy with fatty replacement.

A case of small undifferentiated pancreatic carcinoma detected during follow-up for focal pancreatic parenchymal atrophy with fatty replacement.

Journal: Clinical journal of gastroenterology

Published: August 08, 2025

Successful treatment of myeloid blast phase chronic myelogenous leukemia with the JAK2 V617 F mutation by combination therapy with asciminib and ropeginterferon alfa-2b in an elderly patient.

Successful treatment of myeloid blast phase chronic myelogenous leukemia with the JAK2 V617 F mutation by combination therapy with asciminib and ropeginterferon alfa-2b in an elderly patient.

Journal: International journal of hematology

Published: February 06, 2025

Successful treatment with Pola-R-mini-CHP for elderly relapsed and refractory mantle cell lymphoma.

Successful treatment with Pola-R-mini-CHP for elderly relapsed and refractory mantle cell lymphoma.

Journal: Annals of hematology

Published: July 29, 2024

Immunohistochemistry for YAP1 N-terminus and C-terminus highlights metaplastic thymoma and high-grade thymic epithelial tumors by different staining patterns.

Immunohistochemistry for YAP1 N-terminus and C-terminus highlights metaplastic thymoma and high-grade thymic epithelial tumors by different staining patterns.

Journal: Virchows Archiv : an international journal of pathology

Published: June 22, 2024

Insulin-like Growth Factor II mRNA-binding Protein 3 is a Highly Sensitive Marker for Intravascular Large B-cell Lymphoma: Immunohistochemical Analysis of 152 Pathology Specimens From 88 Patients.

Insulin-like Growth Factor II mRNA-binding Protein 3 is a Highly Sensitive Marker for Intravascular Large B-cell Lymphoma: Immunohistochemical Analysis of 152 Pathology Specimens From 88 Patients.

Journal: The American journal of surgical pathology

Published: March 18, 2024

Showing 1-12 of 62

Last Updated: 09/26/2026